These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1387799)

  • 21. Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril.
    van Wijngaarden J; Pinto YM; van Gilst WH; de Graeff PA; de Langen CD; Wesseling H
    Cardiovasc Res; 1991 Nov; 25(11):936-42. PubMed ID: 1813122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction.
    Westendorp B; Schoemaker RG; Buikema H; de Zeeuw D; van Veldhuisen DJ; van Gilst WH
    J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):27-32. PubMed ID: 15136971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Captopril and ramiprilat protect against free radical injury in isolated working rat hearts.
    Pi XJ; Chen X
    J Mol Cell Cardiol; 1989 Dec; 21(12):1261-71. PubMed ID: 2698963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of tissue affinity of angiotensin-converting enzyme inhibitors on left ventricular remodeling after myocardial infarction.
    Konermann M; Altmann C; Laschewski F; Josephs W; Odenthal HJ; Horstmann E; Sanner B
    Clin Cardiol; 1998 Apr; 21(4):277-85. PubMed ID: 9562938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kallidin-like peptide mediates the cardioprotective effect of the ACE inhibitor captopril against ischaemic reperfusion injury of rat heart.
    Liu X; Lukasova M; Zubakova R; Lewicka S; Hilgenfeldt U
    Br J Pharmacol; 2006 Jul; 148(6):825-32. PubMed ID: 16770319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of zofenopril on myocardial ischemia in post-myocardial infarction patients with preserved left ventricular function: the Survival of Myocardial Infarction Long-term Evaluation (SMILE)-ISCHEMIA study.
    Borghi C; Ambrosioni E;
    Am Heart J; 2007 Mar; 153(3):445.e7-14. PubMed ID: 17307427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection of ischemic heart from reperfusion injury by myo-inositol hexaphosphate, a natural antioxidant.
    Rao PS; Liu XK; Das DK; Weinstein GS; Tyras DH
    Ann Thorac Surg; 1991 Oct; 52(4):908-12. PubMed ID: 1929656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pretreatment with captopril improves myocardial recovery after cardioplegic arrest.
    Menasché P; Grousset C; Peynet J; Mouas C; Bloch G; Piwnica A
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):402-7. PubMed ID: 1378121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Captopril cardioplegia on myocardial protection in the hypertrophied rat hearts.
    Zhang YH; Xu SC
    Int J Cardiol; 1994 Dec; 47(2):131-7. PubMed ID: 7721480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and preclinical in vivo pharmacology.
    DeForrest JM; Waldron TL; Harvey C; Scalese B; Rubin B; Powell JR; Petrillo EW; Cushman DW
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):730-6. PubMed ID: 2481187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury: an overview.
    Zughaib ME; Sun JZ; Bolli R
    Basic Res Cardiol; 1993; 88 Suppl 1():155-67. PubMed ID: 8357331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of ACE inhibitor captopril and L-arginine on the metabolism and on ischemia-reperfusion injury of the isolated rat heart.
    Divisová J; Vavrínková H; Tutterová M; Kazdová L; Meschisvili E
    Physiol Res; 2001; 50(2):143-52. PubMed ID: 11522042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early treatment of acute myocardial infarction with angiotensin-converting enzyme inhibition: safety considerations. SMILE pilot study working party.
    Ambrosioni E; Borghi C; Magnani B
    Am J Cardiol; 1991 Nov; 68(14):101D-110D. PubMed ID: 1746414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is the tissue affinity of ACE inhibitors of relevance for the remodeling of the left ventricular wall following myocardial infarction? Estimations with cine magnetic resonance imaging.
    Konermann M; Sanner BM; Altmann C; Laschewski F; Rawert B; Trappe HJ
    Cardiology; 2000; 94(3):179-87. PubMed ID: 11279324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beneficial effect of captopril against ischaemia-reperfusion injury in isolated guinea pig hearts.
    Doğan R; Sarigül A; Isbir S; Farsak B; Tuncer M; Kilinç K; Demircin M
    Scand J Clin Lab Invest; 1998 Apr; 58(2):119-26. PubMed ID: 9587163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Captopril and its time of administration in myocardial ischaemic-reperfusion injury.
    Maulik SK; Kumari R; Maulik M; Manchanda SC; Gupta SK
    Pharmacol Res; 2001 Aug; 44(2):123-8. PubMed ID: 11516262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension.
    Napoli C; Sica V; de Nigris F; Pignalosa O; Condorelli M; Ignarro LJ; Liguori A
    Am Heart J; 2004 Jul; 148(1):e5. PubMed ID: 15215814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
    Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA
    Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of myocardial ischemic reperfusion injury by sialylated glycosphingolipids, gangliosides.
    Maulik N; Das DK; Gogineni M; Cordis GA; Avrova N; Denisova N
    J Cardiovasc Pharmacol; 1993 Jul; 22(1):74-81. PubMed ID: 7690100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antioxidant and cardioprotective properties of the sulphydryl angiotensin-converting enzyme inhibitor zofenopril.
    Evangelista S; Manzini S
    J Int Med Res; 2005; 33(1):42-54. PubMed ID: 15651714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.